by European Public Health Alliance | Mar 2, 2016 | Opinion
by Yannis Natsis Policy Coordinator Universal access and affordable medicines, EPHA Since the start of the Juncker Commission, we are witnessing an awkward new reality. There is no major new health-related legislation heading for the European Parliament, and nothing... by European Public Health Alliance | Mar 2, 2016 | Opinion
In February, trade negotiators from the EU and the US met in Brussels for the twelfth round of negotiations on the Transatlantic Trade and Investment Partnership (TTIP) – behind closed doors. Amongst other things, they discussed an EU proposal on regulatory...
by European Public Health Alliance | Feb 1, 2016 | Opinion
The Dutch Presidency appears to be keeping its cards close to its chest as far as pharmaceuticals and public health are concerned. So far, they seem to have been purposefully ambiguous about their intentions and have not put forward any concrete proposals on the...
by European Public Health Alliance | Feb 1, 2016 | Opinion
Many people are already embracing the possibilities of eHealth but what is preventing eHealth from becoming a widespread reality? And what could be the potential solutions? The eHealth revolution has been a slow burner for many years but the advent of mobile and...
by European Public Health Alliance | Feb 1, 2016 | Opinion
“The astronomical and immorally high prices of medicines in Greece and internationally create a situation of social cannibalism, as patients are forced to compete for the treatments they need”. This is the situation according to Yannis Natsis, Policy Coordinator on...
by EPHA | Jan 30, 2016 | Opinion
Worthy of mention are the Opinions by Advocate General Kokott on three tobacco cases supporting the legality of the Tobacco Products Directive. The opinions conclude that the Directive’s packaging and labeling requirements are proportionate, that the ban on menthol...
